Medigen Vaccine Biologics Corporation (TPEX: 6547)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.30
+0.70 (1.86%)
Nov 22, 2024, 1:30 PM CST

Medigen Vaccine Biologics Market Cap

Medigen Vaccine Biologics has a market cap or net worth of 12.59 billion as of November 22, 2024. Its market cap has decreased by -45.99% in one year.

Market Cap
12.59B
Enterprise Value
11.12B
Revenue
648.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.30

Market Cap Chart

Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 12.59B, an increase of 344.11%. That is a compound annual growth rate of 17.39%.

History

DateMarket Cap% Change
Nov 20, 202412.31B-46.56%
Dec 29, 202323.04B1.10%
Dec 30, 202222.78B-64.20%
Dec 30, 202163.65B192.75%
Dec 31, 202021.74B388.97%
Dec 31, 20194.45B-18.31%
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition